Medicus Pharma Ltd. Completes Acquisition of Antev Limited
Antev is developing Teverelix, a next generation GnRH Antagonist, as a first in class market product for Acute Urinary Retention...
Cancer
Semaglutide API Delivery Enables Start of Lab-Scale ODF Development at BioNxt
VANCOUVER, BC / ACCESS Newswire / September 2, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:XPHYF)(FSE:4XT) is...
Defence Therapeutics Engages Dr. Amie Phinney as Strategy & Business Advisor to Guide Next Phase of Growth
Montreal, Quebec--(Newsfile Corp. - September 2, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the...
Digital Pathology Market to Grow at a CAGR of 7.8% from 2025 to 2032 | SkyQuest Technology Consulting
The digital pathology market is anticipated to increase due to the global increase in chronic conditions like cancer, cardiovascular disorders,...
Boehringer’s HERNEXEOS® approved in China as first oral targeted therapy for previously treated patients with HER2-mutant advanced NSCLC
Illustrative image Laboratory, Boehringer Ingelheim This press release is not intended for UK and US media. HERNEXEOS® (zongertinib tablets) has been...
Taiwan Showcases Smart Healthcare Breakthroughs at Taiwan Expo USA 2025
DALLAS, Aug. 31, 2025 /PRNewswire/ -- At Taiwan Expo USA 2025 in Dallas, the Smart Healthcare Pavilion, organized by the...
Novartis Leqvio® shows statistically significant and clinically meaningful early LDL-C goal achievement with less muscle pain
V-DIFFERENCE is first study to show that Leqvio prioritized after statins helps more patients achieve guideline low-density lipoprotein cholesterol (LDL-C)...
Near infrared Imaging Market worth US$2.07 billion by 2030 with 10.6% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Aug. 30, 2025 /PRNewswire/ -- The global Near infrared Imaging Market, valued at US$9.69 billion in 2023, stood...
Altamira Therapeutics Provides Business Update and First Half 2025 Financial Results
Company to host webcast today at 8.00 a.m. ETGrowing portfolio of RNA delivery clients and programsAdvancing plans for partial spin-off...
Pasithea Therapeutics Updates Time of Presentation at the H.C. Wainwright 27th Annual Global Investment Conference
MIAMI, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company...
Justice Secured for Late Air Force Veteran, James Doherty, Sr. in Landmark Nursing Home Elder Neglect Trial
LONG BEACH, Calif., Aug. 28, 2025 /PRNewswire/ -- In a groundbreaking jury trial that marks a significant victory for the...
Solv Wellness® Launches Menopause Made Clear™ to Tackle Critical Gaps in Menopause
ATLANTA, Aug. 28, 2025 /PRNewswire/ -- While every woman who lives long enough will experience menopause, it is one of...
Five Mothers Unite in First-Ever Collaboration to Fund $1.5 Million Groundbreaking Ewing Sarcoma Grant
Los Angeles, California--(Newsfile Corp. - August 28, 2025) - In a powerful act of unity and determination, five mothers—each having...
Black Book Research Unveils First Pan-European Study of EHDS Interoperability Vendors as Hospitals Brace for 2026 Compliance Deadline
Independent Benchmarking Across 13 EU Countries and the UK Reveals Vendor Readiness and Country Gaps Ahead of EHDS Enforcement LONDON,...
Telomir Pharmaceuticals Reports In Vitro Data Supporting the Potential of Telomir-1 as a First-in-Class Epigenetic Therapy Influencing DNA Methylation Pathways in Cancer, Aging, and Age-Related Diseases
In vitro findings reveal Telomir-1's dual action: targeting DNA methylation switches and cutting into the Wnt "fuel line" that drives...
Can-Fite Reports H1 2025 Financial Results and Clinical Update
Ramat Gan, Israel, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company...
The International Myeloma Foundation Revives ‘Do You #kNOwMyeloma?’ for Blood Cancer Awareness Month 2025
STUDIO CITY, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- With Blood Cancer Awareness Month coming up this September, the International...
CytoDyn to Present at the H.C. Wainwright 27th Annual Global Investment Conference
VANCOUVER, Washington, Aug. 28, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage biotechnology company advancing...
Aprea Therapeutics to Present at H.C. Wainwright Global Investment Conference
DOYLESTOWN, Pa., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company...
Moleculin Announces Exercise of Warrants for $6.0 Million Gross Proceeds
HOUSTON, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company...